The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality ...
But MicroStrategy’s recent decision to rebrand to Strategy is a stroke of genius, and you could argue it’s long overdue. This ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果